Evidence map›Paper›PMID 27633982›Full record

ArticleAddiction science & clinical practice2016

Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness.

Alex H S Harris, Thomas Bowe, Hildi Hagedorn, Andrea Nevedal, Andrea K Finlay, Risha Gidwani, Craig Rosen, Chad Kay, Melissa Christopher

Open access · goldAbstract read
In one paragraph

Article in Addiction science & clinical practice, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
12.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Alex H S HarrisCenter for Innovation to Implementation, Health Services Research and Development, VA Palo Alto Health Care System, Menlo Park, CA, USA. Alexander.Harris2@va.gov.
Thomas BoweCenter for Innovation to Implementation, Health Services Research and Development, VA Palo Alto Health Care System, Menlo Park, CA, USA.
Hildi HagedornCenter for Chronic Disease Outcomes Research, Health Services Research and Development, VA Minneapolis Health Care System, Minneapolis, MN, USA.
Andrea NevedalCenter for Innovation to Implementation, Health Services Research and Development, VA Palo Alto Health Care System, Menlo Park, CA, USA.
Andrea K FinlayCenter for Innovation to Implementation, Health Services Research and Development, VA Palo Alto Health Care System, Menlo Park, CA, USA.
Risha GidwaniCenter for Innovation to Implementation, Health Services Research and Development, VA Palo Alto Health Care System, Menlo Park, CA, USA.
Craig RosenCenter for Innovation to Implementation, Health Services Research and Development, VA Palo Alto Health Care System, Menlo Park, CA, USA.
Chad KayPharmacy Benefits Management, Academic Detailing Program, VA San Diego Health Care System, San Diego, CA, USA.
Melissa ChristopherPharmacy Benefits Management, Academic Detailing Program, VA San Diego Health Care System, San Diego, CA, USA.
Center for Innovation · USHealth Services Research & Development · US

Funding

Justice-Involved Veterans: Mental Health and Substance Use Care of Young AdultsIK2HX001513 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI FINLAY, ANDREA K · 2019 to 2020
–
HSRD VA IK2 HX001513HSRD VA RCS 14-232
6 · The paper itself

Abstract

backgroundActive consideration of effective medications to treat alcohol use disorder (AUD) is a consensus standard of care, yet knowledge and use of these medications are very low across diverse settings. This study evaluated the overall effectiveness a multifaceted academic detailing program to address this persistent quality problem in the US Veterans Health Administration (VHA), as well as the context and process factors that explained variation in effectiveness across sites.

methodsAn interrupted time series design, analyzed with mixed-effects segmented logistic regression, was used to evaluate changes in level and rate of change in the monthly percent of patients with a clinically documented AUD who received naltrexone, acamprosate, disulfiram, or topiramate. Using data from a 20 month post-implementation period, intervention sites (n = 37) were compared to their own 16 month pre-implementation performance and separately to the rest of VHA.

resultsFrom immediately pre-intervention to the end of the observation period, the percent of patients in the intervention sites with AUD who received medication increased over 3.4 % in absolute terms and 68 % in relative terms (i.e., 4.9-8.3 %). This change was significant compared to the pre-implementation period in the intervention sites and secular trends in control sites. Sites with lower pre-implementation adoption, more person hours of detailing, but fewer people detailed, had larger immediate increases in medication receipt after implementation. The average number of detailing encounters per person was associated with steeper increases in slope over time.

conclusionsThis study found empirical support for a multifaceted quality improvement strategy aimed at increasing access to and utilization of pharmacotherapy for AUD. Future studies should focus on determining how to enhance the programs effects, especially in non-responsive locations.

Indexed as

AcamprosateAdultAlcohol DeterrentsAlcohol-Related DisordersDisulfiramFemaleFructoseHumansMaleMiddle AgedNaltrexonePatient ComplianceTaurineTopiramateUnited StatesUnited States Department of Veterans AffairsAcamprosateAlcohol DeterrentsDisulfiramFructoseNaltrexoneTaurineTopiramateAlcohol use disorderGuideline adherenceImplementationMedication assisted treatmentPharmacotherapyPractice guidelinesQuality improvement

Identifiers

PMID27633982
PMCPMC5025587
OpenAlexW2519862705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.